{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2002"],"data_sharing_plan":["IPD Sharing (as of September 2019): Yes\nDescription: http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf\nURL: http://engagezone.msd.com/ds_documentation.php"],"condition":["Adenomatous Polyposis Coli","Colorectal Neoplasms","Nasopharyngeal Neoplasms","Osteoarthritis"],"disease":["Adenomatous Polyposis Coli","Colorectal Neoplasms","Nasopharyngeal Neoplasms","Osteoarthritis"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2015062"],"study_start_month":["8"],"keyword":["Rofecoxib","Cancer Pain"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)","description":"A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.","dates":{"creation":"2002-08-15"},"accession":"2015062","cross_references":{"ClinicalTrials___gov":["NCT00140894"]}}